The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation
Abstract
Donor organ shortages for transplantation remain a serious global concern, and alternative treatment is in high demand. Fetal cells and tissues have considerable therapeutic potential as, for example, organoid technology that uses human induced pluripotent stem cells (hiPSCs) to generate unlimited human fetal-like cells and tissues. We previously reported the in vivo vascularization of early fetal liver–like hiPSC-derived liver buds (LBs) and subsquent improved survival of recipient mice with subacute liver failure. Here, we show hiPSC–liver organoids (LOs) that recapitulate midgestational fetal liver promote de novo liver generation when grafted onto the surface of host livers in chemical fibrosis models, thereby recovering liver function. We found that fetal liver, a hematopoietic tissue, highly expressed macrophage-recruiting factors and antifibrotic M2 macrophage polarization factors compared with the adult liver, resulting in fibrosis reduction because of CD163 + M2-macrophage polarization. Next, we created midgestational fetal liver–like hiPSC-LOs by fusion of hiPSC-LBs to induce static cell-cell interactions and found that these contained complex structures such as hepatocytes, vasculature, and bile ducts after transplantation. This fusion allowed the generation of a large human tissue suitable for transplantation into immunodeficient rodent models of liver fibrosis. hiPSC-LOs showed superior liver function compared with hiPSC-LBs and improved survival and liver function upon transplantation. In addition, hiPSC-LO transplantation ameliorated chemically induced liver fibrosis, a symptom of liver cirrhosis that leads to organ dysfunction, through immunomodulatory effects, particularly on CD163 + phagocytic M2-macrophage polarization. Together, our results suggest hiPSC-LO transplantation as a promising therapeutic option for liver fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“Previously, we generated hiPSC–liver buds (LBs) by mimicking the process of early liver development ( 5 , 8 ).”
MethodSelf-citationA phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309000 · Cited by 2,084
Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro
Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K., Hoskins, E. E., Kalinichenko, V. V., Wells, S. I., Zorn, A. M., et al. (2011) · Nature · doi:10.1038/nature09691 · Cited by 1,922
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Trounson, A., & McDonald, C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.007 · Cited by 1,468
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
Hoeffel, G., Chen, J., Lavin, Y., Low, D., Almeida, F. F., See, P., Beaudin, A. E., Lum, J., Low, I., Forsberg, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.011 · Cited by 1,135 · cited 1×
“In the developing liver, stellate cells and ECs express the MF-recruiting factor CSF1, resulting in the influx of yolk sac–derived MFs followed by gradual replacement with monocyte-derived MFs ( 17 , 42 ).”
BackgroundHuman cerebral organoids recapitulate gene expression programs of fetal neocortex development
Camp, J. G., Badsha, F., Florio, M., Kanton, S., Gerber, T., Wilsch-Bräuninger, M., Lewitus, E., Sykes, A., Hevers, W., Lancaster, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520760112 · Cited by 1,130
Cited by
Wang, J., Zhan, H., Wang, Y., Zhao, L., Huang, Y., & Wu, R. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03989-6 · Cited by 33
Organoids for tissue repair and regeneration
Yu, B., Zhou, D., Wang, F., Chen, X., Li, M., & Su, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102013 · Cited by 40
Remodeling of senescent macrophages in synovium alleviates trauma- and aging-induced osteoarthritis
Liu, Y., Duan, J., Dang, Y., Hao, R., Wang, H., Tan, E., Wang, R., Li, Y., Zhang, S., Wang, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.016 · Cited by 42
Panferov, E., Dodina, M., Reshetnikov, V. V., Ryapolova, A., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125617 · Cited by 28
Advances in liver and pancreas organoids: how far we have come and where we go next
Sljukic, A., Jenkinson, J. G., Niksic, A., Prior, N., & Huch, M. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01116-1 · Cited by 26
Metadata
- Authors
- Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., Zushi, M., Yajima, M., Kobayashi, T., Hasegawa, S., Kawakatsu-Hatada, Y., Hayashi, Y., Osakabe, S., Maeda, T., Kimura, K., Mori, A., Tanaka, M., Kamishibahara, Y., Matsuo, M., Nie, Y.-Z., Okamoto, S., Oba, T., Tanimizu, N., & Taniguchi, H.
- Affiliations
- Institute of Medical Science, The University of Tokyo (JP)
- Yokohama City University (JP)
- Department of Regenerative Medicine, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
- Corresponding author
- Tadokoro, Tomomi
- Taniguchi, Hideki
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2024-07-24
- Volume
- 16
- Issue
- 757
- Pages
- eadg0338-eadg0338
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4400945382
- Cited by
- 58
- References
- 54
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 3
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23K08053, 22K08807)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- human induced pluripotent stem cells, liver organoids, liver fibrosis, liver transplantation, M2 macrophage polarization, CD163, immunomodulation, cell fusion, liver cirrhosis, hepatocyte differentiation, vascularization
- MeSH terms
- Animals, Humans, Liver, Liver Cirrhosis, Macrophages, Organoids, Liver Transplantation, Mice, Immunomodulation, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation. https://app.cochat.ai/papers/10.1126/scitranslmed.adg0338
- The paper
- Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., Zushi, M., Yajima, M., Kobayashi, T., Hasegawa, S., Kawakatsu-Hatada, Y., Hayashi, Y., Osakabe, S., Maeda, T., Kimura, K., . . . Taniguchi, H. (2024). Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adg0338
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.